Review: taking Citalopram hydrobromide and Seroquel together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Seroquel together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Seroquel. It is created by eHealthMe based on reports of 4,695 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Citalopram hydrobromide and Seroquel >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 24,533 users)

Seroquel

Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. (latest outcomes from Seroquel 80,495 users)

On Aug, 22, 2016

4,695 people who take Citalopram Hydrobromide, Seroquel are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Seroquel drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 16.0% - (4 of 25 people)
  • 6 - 12 months: 23.0% - (4 of 17 people)
  • 1 - 2 years: 38.0% - (13 of 34 people)
  • 2 - 5 years: 35.0% - (11 of 31 people)
  • 5 - 10 years: 52.0% - (10 of 19 people)
  • 10+ years: 42.0% - (3 of 7 people)
  • not specified: 0.0% - (0 of 1 people)
Seroquel:
  • < 1 month: 17.0% - (3 of 17 people)
  • 1 - 6 months: 30.0% - (12 of 39 people)
  • 6 - 12 months: 57.0% - (11 of 19 people)
  • 1 - 2 years: 54.0% - (12 of 22 people)
  • 2 - 5 years: 46.0% - (12 of 26 people)
  • 5 - 10 years: 42.0% - (6 of 14 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 2 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 34.0% - (35 of 101 people)
  • male: 26.0% - (10 of 38 people)
Seroquel:
  • female: 39.0% - (41 of 103 people)
  • male: 43.0% - (18 of 41 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 41.0% - (5 of 12 people)
  • 20-29: 25.0% - (6 of 24 people)
  • 30-39: 28.0% - (11 of 38 people)
  • 40-49: 37.0% - (12 of 32 people)
  • 50-59: 39.0% - (9 of 23 people)
  • 60+: 22.0% - (2 of 9 people)
Seroquel:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 46.0% - (7 of 15 people)
  • 20-29: 45.0% - (11 of 24 people)
  • 30-39: 39.0% - (15 of 38 people)
  • 40-49: 50.0% - (16 of 32 people)
  • 50-59: 28.0% - (7 of 25 people)
  • 60+: 33.0% - (3 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • suicide attempt
  • loss of consciousness
  • type 2 diabetes mellitus
  • diabetes mellitus
  • depression
  • hyperglycaemia
  • sopor
  • suicidal ideation
  • somnolence
  • agitation
1 - 6 months:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • blood cholesterol increased
  • suicidal ideation
  • weight increased
  • hyperlipidaemia
  • neuropathy peripheral
  • diabetic neuropathy
  • type 1 diabetes mellitus
6 - 12 months:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
  • type 1 diabetes mellitus
  • diabetic neuropathy
  • diabetes mellitus inadequate control
  • hyperglycaemia
  • pancreatitis acute
  • cardiac disorder
  • blood cholesterol increased
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus inadequate control
  • hyperlipidaemia
  • diabetic neuropathy
  • insomnia
  • obesity
  • hyperglycaemia
  • neuropathy peripheral
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • diabetic neuropathy
  • hyperglycaemia
  • diabetes mellitus inadequate control
  • weight increased
  • insomnia
  • hypoglycaemia
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • hyperlipidaemia
  • obesity
  • diabetic neuropathy
  • type 1 diabetes mellitus
  • hyperglycaemia
  • back pain
  • blood triglycerides increased
10+ years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • neuropathy peripheral
  • blood cholesterol increased
  • dizziness
  • fall
  • musculoskeletal discomfort
  • pain
  • renal failure
  • weight decreased
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • depression
  • anxiety
  • weight increased
  • suicidal ideation
  • drug ineffective
  • somnolence
  • blood cholesterol increased

Most common drug interactions by gender *:

female:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • insomnia
  • blood cholesterol increased
  • weight increased
  • depression
  • diabetes mellitus inadequate control
  • somnolence
  • diabetic neuropathy
  • obesity
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • anxiety
  • depression
  • suicidal ideation
  • tremor
  • feeling abnormal
  • weight decreased
  • weight increased

Most common drug interactions by age *:

0-1:
  • neonatal respiratory distress syndrome
  • premature baby
  • drug withdrawal syndrome neonatal
  • hypocalcaemia
  • pneumothorax
  • convulsion
  • diabetes mellitus
  • maternal drugs affecting foetus
  • agitation neonatal
  • hypotension
2-9:
  • acute stress disorder
  • adverse drug reaction
  • anxiety
  • asthenia
  • bronchitis
  • confusional state
  • crying
  • drug withdrawal syndrome
  • feeling abnormal
  • hypoproteinaemia
10-19:
  • diabetic ketoacidosis
  • diabetes mellitus
  • weight increased
  • depression
  • suicidal ideation
  • motion sickness
  • aggression
  • anxiety
  • diabetic retinopathy
  • hyperglycaemia
20-29:
  • type 2 diabetes mellitus
  • insomnia
  • depression
  • drug ineffective
  • blood cholesterol increased
  • suicidal ideation
  • vomiting
  • diabetes mellitus
  • somnolence
  • anxiety
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • diabetes mellitus inadequate control
  • obesity
  • blood cholesterol increased
  • hyperglycaemia
  • pancreatitis
  • suicidal ideation
  • back pain
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • insomnia
  • depression
  • blood cholesterol increased
  • suicidal ideation
  • diabetic neuropathy
  • anxiety
  • adverse event
  • disturbance in attention
50-59:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • insomnia
  • diabetes mellitus inadequate control
  • blood cholesterol increased
  • hyperglycaemia
  • diabetic neuropathy
  • anxiety
  • weight increased
  • neuropathy peripheral
60+:
  • insomnia
  • depression
  • fall
  • malaise
  • fatigue
  • anxiety
  • somnolence
  • tremor
  • nausea
  • agitation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Seroquel?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Seroquel

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Seroquel

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Seroquel (quetiapine fumarate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.